Prosecution Insights
Last updated: August 18, 2026

Examiner: VARGAS, ANNA ELIZABETH

Tech Center 3700 • Art Units: 3783

This examiner grants 60% of resolved cases

Performance Statistics

59.7%
Allow Rate
-10.3% vs TC avg
164
Total Applications
+54.1%
Interview Lift
1199
Avg Prosecution Days
Based on 129 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
16.6%
§102 Novelty
52.9%
§103 Obviousness
28.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17661147 PATIENT RATIO ADJUSTMENT FOR FLUID DELIVERY DETERMINATION Non-Final OA Medtronic MiniMed, Inc.
17352154 IRREMOVABLE BUCKLING-RESISTANT FLEXIBLE CANNULA AND PROCESS Non-Final OA Medtronic MiniMed, Inc.
16022471 ADMINISTRATION APPARATUS Final Rejection DAICEL CORPORATION
16022487 INJECTION APPARATUS Final Rejection Daicel Corporation
18595872 CONNECTED INJECTION DEVICES WITH STATUS SENSING SYSTEMS Non-Final OA ELI LILLY AND COMPANY
17034308 COLLAPSIBLE CATHETER Non-Final OA ABIOMED, Inc.
17396426 AUTOMATICALLY-LOCKING VACUUM SYRINGES, AND ASSOCIATED SYSTEMS AND METHODS Non-Final OA Inari Medical, Inc.
18620385 ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE Final Rejection Sanofi
16630774 METHODS FOR TREATING CONGENITAL HYPERINSULINISM Final Rejection XERIS PHARMACEUTICALS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month